Undisclosed oncolytic bacterial therapy / Shenzhen Synthetica Pioneering - LARVOL DELTA

Synthetica Pioneering Closes a Series A Funding Round to Support Development of Oncolytic Bacterial Therapy for Solid Tumors (PRNewswire) - "Shenzhen Synthetica Pioneering Co., Ltd...has recently closed a Series A funding round, led by Boehringer Ingelheim Venture Fund and Temasek, with additional participation from Lenovo Capital, Fosun Health Capital and ATLATL Summer Fund. The funding will be used to fast-track Synthetica's oncolytic bacterial pipelines into clinical trials."

Financing • Solid Tumor